Literature DB >> 16836989

Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells.

Dursun Gündüz1, Sascha A Kasseckert, Frauke V Härtel, Muhammad Aslam, Yaser Abdallah, Matthias Schäfer, Hans Michael Piper, Thomas Noll, Claudia Schäfer.   

Abstract

OBJECTIVE: Ischemia-reperfusion provokes barrier failure of the coronary microvasculature, leading to myocardial edema development that jeopardizes functional recovery of the heart during reperfusion. Here, we tested whether adenosine 5'-triphosphate (ATP), either exogenously applied or spontaneously released during reperfusion, protects the endothelial barrier against an imminent reperfusion injury and whether interventions preventing ATP breakdown augment this protective ATP effect.
METHODS: Cultured microvascular coronary endothelial monolayers and isolated-perfused hearts of rat were used.
RESULTS: After ischemic conditions were induced, reperfusion of endothelial monolayers activated the endothelial contractile machinery and caused intercellular gap formation. It also led to the release of ATP. When its breakdown was inhibited by 6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP (ARL 67156; 100 microM), a selective ectonucleotidase inhibitor, contractile activation and gap formation were significantly reduced. Reperfusion in the presence of exogenously added ATP (10 microM) plus ARL caused an additional reduction of both aforementioned effects. In contrast, elevation of ATP degradation by apyrase (1 U/ml), a soluble ectonucleotidase, or addition of adenosine (10 microM) provoked an increase in gap formation during reperfusion that could be completely inhibited by 8-phenyltheophylline (8-PT; 10 microM), an adenosine receptor antagonist. In Langendorff-perfused rat hearts, the reperfusion-induced increase in water content was significantly reduced by ARL plus ATP. Under conditions favouring ATP degradation, an increase in myocardial edema was observed that could be blocked by 8-PT.
CONCLUSION: ATP, either released from cells or exogenously applied, protects against reperfusion-induced failure of the coronary endothelial barrier. Inhibition of ATP degradation enhances the stabilizing effect of ATP on barrier function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16836989     DOI: 10.1016/j.cardiores.2006.06.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

Review 1.  The touching story of purinergic signaling in epithelial and endothelial cells.

Authors:  Jenny Öhman; David Erlinge
Journal:  Purinergic Signal       Date:  2012-04-24       Impact factor: 3.765

2.  ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.

Authors:  David Lu; Sahar Soleymani; Rohit Madakshire; Paul A Insel
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

3.  Could early ischemic arrhythmia triggered by purinergic activation of the transient receptor potential channels be prevented by creatine?

Authors:  Guy Vassort; Patrice Bideaux; Julio Alvarez
Journal:  Exp Clin Cardiol       Date:  2010

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Investigation of therapeutic potential and molecular mechanism of vitamin P and digoxin in I/R-induced myocardial infarction in rat.

Authors:  Harwinder Singh; Parneet Kaur; Pradeep Kaur; Arunachalam Muthuraman; Gurpreet Singh; Manjinder Kaur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-19       Impact factor: 3.000

Review 6.  Purinergic signaling in myocardial ischemia-reperfusion injury.

Authors:  Yi Zhuang; Mei-Ling Yu; Sheng-Feng Lu
Journal:  Purinergic Signal       Date:  2022-03-07       Impact factor: 3.765

7.  Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.

Authors:  Muhammad Aslam; Klaus-Dieter Schluter; Susanne Rohrbach; Amir Rafiq; Sabiha Nazli; Hans Michael Piper; Thomas Noll; Rainer Schulz; Dursun Gündüz
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

8.  High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury.

Authors:  An L Moens; Hunter C Champion; Marc J Claeys; Barbara Tavazzi; Pawel M Kaminski; Michael S Wolin; Dirk J Borgonjon; Luc Van Nassauw; Azeb Haile; Muz Zviman; Djahida Bedja; Floris L Wuyts; Rebecca S Elsaesser; Paul Cos; Kathy L Gabrielson; Giuseppe Lazzarino; Nazareno Paolocci; Jean-Pierre Timmermans; Christiaan J Vrints; David A Kass
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

9.  Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart.

Authors:  Dursun Gündüz; Christian W Hamm; Muhammad Aslam
Journal:  J Vis Exp       Date:  2017-05-19       Impact factor: 1.355

10.  Administration of exogenous adenosine triphosphate to ischemic skeletal muscle induces an energy-sparing effect: role of adenosine receptors.

Authors:  Claudio Maldonado; Sathnur B Pushpakumar; Gustavo Perez-Abadia; Sengodagounder Arumugam; Andrew N Lane
Journal:  J Surg Res       Date:  2012-07-06       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.